Название
Aim. To assess the efficacy of FLAG/FLAG-Ida regimen and to identify factors that influence remission, duration of disease-free survival (DFS) and overall survival (OS) of patients with relapsed/refractory acute myeloid leukemia (AML). Materials & Methods. The trial included 54 patients (28 men...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2019-05-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: |
http://bloodjournal.ru/wp-content/uploads/2019/06/7.pdf
|